Pony Testing International Group Co Asset Resilience Ratio

Latest as of March 2026: 11.99%

Pony Testing International Group Co asset resilience ratio. Pony Testing International Group Co (300887) has an Asset Resilience Ratio of 11.99% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300887 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥393.00 Million
≈ $57.51 Million USD Cash + Short-term Investments

Total Assets

CN¥3.28 Billion
≈ $479.61 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio of Pony Testing International Group Co (2020–2025)

Asset resilience ratio of Pony Testing International Group Co from 2020 to 2025. This chart shows how Pony Testing International Group Co's Asset Resilience Ratio has changed over time. Read total liabilities of Pony Testing International Group Co for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Pony Testing International Group Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Pony Testing International Group Co balance sheet assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥393.00 Million 11.99%
Total Liquid Assets CN¥393.00 Million 11.99%

Asset Resilience Insights

  • Moderate Liquidity: Pony Testing International Group Co has 11.99% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Pony Testing International Group Co Industry Peers by Asset Resilience Ratio

Compare Pony Testing International Group Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Diversified Royalty Corp
TO:DIV
Specialty Business Services 0.75%
Votum SA
WAR:VOT
Specialty Business Services 3.88%
GKW Limited
NSE:GKWLIMITED
Specialty Business Services 8.22%
Energy Action Ltd
AU:EAX
Specialty Business Services 7.15%
SSH Group Ltd
AU:SSH
Specialty Business Services 9.71%
Brambles Ltd
AU:BXB
Specialty Business Services 1.84%
Smartgroup Corporation Ltd
AU:SIQ
Specialty Business Services 6.11%
Mader Group Ltd
AU:MAD
Specialty Business Services 4.89%

Pony Testing International Group Co Asset Resilience Ratio by Year (2020–2025)

Pony Testing International Group Co asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for Pony Testing International Group Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 8.32% CN¥280.00 Million
≈ $40.97 Million
CN¥3.36 Billion
≈ $492.23 Million
+1.17pp
2024-12-31 7.15% CN¥275.00 Million
≈ $40.24 Million
CN¥3.84 Billion
≈ $562.44 Million
-5.87pp
2023-12-31 13.03% CN¥565.04 Million
≈ $82.68 Million
CN¥4.34 Billion
≈ $634.79 Million
-4.99pp
2022-12-31 18.02% CN¥825.07 Million
≈ $120.73 Million
CN¥4.58 Billion
≈ $670.19 Million
+11.34pp
2020-12-31 6.67% CN¥141.00 Million
≈ $20.63 Million
CN¥2.11 Billion
≈ $309.22 Million
--
pp = percentage points

About Pony Testing International Group Co

SHE:300887 China Specialty Business Services
Market Cap
$499.12 Million
CN¥3.41 Billion CNY
Market Cap Rank
#11929 Global
#3394 in China
Share Price
CN¥6.25
Change (1 day)
+1.79%
52-Week Range
CN¥6.06 - CN¥15.97
All Time High
CN¥25.78
About

Pony Testing Co., Ltd. provides testing, measurement, calibration, inspection, evaluation, factory inspection, and other professional one-stop technical solutions in China. The company offers biopharmaceutical CRO/CDMO and drug testing services; medical device testing; medical testing/pathological diagnosis; toxicology and pathology experiments; food/liquor/beverage testing; agricultural product … Read more